• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Economics of different treatment options of benign prostatic hyperplasia in Turkey.

作者信息

Ilker Y, Tarcan T, Akdaş A

机构信息

Department of Urology, Marmara University School of Medicine, Istanbul, Turkey.

出版信息

Int Urol Nephrol. 1996;28(4):525-8. doi: 10.1007/BF02550960.

DOI:10.1007/BF02550960
PMID:9119638
Abstract

Benign prostatic hyperplasia (BPH) has an important impact on the national health economics and can be managed in a large spectrum of modalities from simple follow-up to surgery. In this study, we aimed to compare different treatment options of BPH in terms of cost effectiveness in Turkey. The first evaluation of a BPH patient has a cost of $200. The cost of TURP or open prostatectomy (OP) in our hospital including all the expenses is $740. Finasteride has an annual cost nearly equal to TURP and OP. Considering the expenses of the close follow-up studies and regular visits, one-year lasting Finasteride treatment is two times more expensive than surgery. In comparison with medical treatment options, TURP as the gold standard of treatment of BPH is cost effective when long-term expenses are considered.

摘要

相似文献

1
Economics of different treatment options of benign prostatic hyperplasia in Turkey.
Int Urol Nephrol. 1996;28(4):525-8. doi: 10.1007/BF02550960.
2
An economic evaluation of finasteride for treatment of benign prostatic hyperplasia.
Pharmacoeconomics. 1996 May;9(5):443-54. doi: 10.2165/00019053-199609050-00007.
3
Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective.良性前列腺增生的治疗:药物经济学视角
Drugs Aging. 1997 Feb;10(2):107-18. doi: 10.2165/00002512-199710020-00004.
4
Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia.经济建模,以评估非那雄胺、特拉唑嗪及经尿道前列腺切除术治疗中度至重度良性前列腺增生症状男性患者的治疗成本。
Urology. 1995 Oct;46(4):477-83. doi: 10.1016/S0090-4295(99)80258-1.
5
Benign prostatic hyperplasia: cost and effectiveness of three alternative surgical treatment methods used in a Turkish hospital.
J Med Syst. 2005 Oct;29(5):487-92. doi: 10.1007/s10916-005-6105-5.
6
A cost-effectiveness analysis of transurethral resection of the prostate and transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: two-year follow-up.
Scand J Urol Nephrol. 1998 May;32(3):204-10. doi: 10.1080/003655998750015584.
7
Finasteride: an update of its use in the management of symptomatic benign prostatic hyperplasia.非那雄胺:其在有症状良性前列腺增生管理中应用的最新进展
Drugs. 1999 Apr;57(4):557-81. doi: 10.2165/00003495-199957040-00008.
8
An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.多沙唑嗪、非那雄胺及联合疗法治疗良性前列腺增生的经济学评价
Can J Urol. 2004 Aug;11(4):2327-40.
9
Cost-effectiveness analysis of medical treatment of benign prostatic hyperplasia in the Brazilian public health system.巴西公共卫生系统治疗良性前列腺增生的成本效益分析。
Int Braz J Urol. 2012 Sep-Oct;38(5):595-605. doi: 10.1590/s1677-55382012000500003.
10
Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis.医学治疗与经尿道前列腺切除术(TURP)治疗有症状的良性前列腺增生(BPE):成本最小化分析。
World J Urol. 2019 May;37(5):873-878. doi: 10.1007/s00345-018-2454-9. Epub 2018 Aug 25.

引用本文的文献

1
Introduction to the pharmacoeconomics of herbal medicines.
Pharmacoeconomics. 2000 Jul;18(1):1-7. doi: 10.2165/00019053-200018010-00001.

本文引用的文献

1
Patient-perceived health status before and up to 12 months after transurethral resection of the prostate for benign prostatic hypertrophy.经尿道前列腺切除术治疗良性前列腺增生前后直至术后12个月患者自我感知的健康状况。
Br J Urol. 1993 Mar;71(3):297-305. doi: 10.1111/j.1464-410x.1993.tb15946.x.
2
Economic burden of treated benign prostatic hyperplasia in the United Kingdom.英国良性前列腺增生症治疗的经济负担。
Br J Urol. 1993 Mar;71(3):290-6. doi: 10.1111/j.1464-410x.1993.tb15945.x.
3
Cost effectiveness in the management of benign prostatic hyperplasia: Italian data.
Minerva Urol Nefrol. 1994 Jun;46(2):93-9.
4
Urologists on a tightrope: coping with a changing economy.泌尿外科医生如履薄冰:应对不断变化的经济形势。
J Urol. 1994 Jan;151(1):1-4. doi: 10.1016/s0022-5347(17)34857-7.
5
Preliminary results of transurethral microwave thermotherapy in the treatment of benign prostatic hyperplasia in Turkey.经尿道微波热疗治疗土耳其良性前列腺增生症的初步结果。
Eur Urol. 1992;21(3):187-91. doi: 10.1159/000474835.